Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LeMaitre VascularSTU:LHU +1.45%98 ROA % is 10.76% as of Jun. 2026, which is 9% above its 10-year median of 9.88. GuruFocus rates STU:LHU with a GF Score™ of 98/100 and a GF Value™ of €81.33 (Modestly Undervalued). Among 854 Medical Devices & Instruments companies, LeMaitre Vascular ranks better than 88.41% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. LeMaitre Vascular's annualizedNet Income for the quarter that ended in Jun. 2026 was €59.2 Mil.
LeMaitre Vascular's average Total Assets over the quarter that ended in Jun. 2026 was €550.3 Mil. Therefore, LeMaitre Vascular's annualized ROA % for the quarter that ended in Jun. 2026 was 10.76%.
The historical rank and industry rank for LeMaitre Vascular's ROA % or its related term are showing as below:
STU:LHU'
s ROA % Range Over the Past 10 Years
Min: 6.84 Med: 9.88 Max: 16.42
Current: 10.73
During the past 13 years, LeMaitre Vascular's highest ROA % was 16.42%. The lowest was 6.84%. And the median was 9.88%.
STU:LHU's ROA % is ranked better than 88.41% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.525
vs STU:LHU: 10.73
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Jun. 2026) net income data. The Revenue data used here is four times the quarterly (Jun. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
LeMaitre Vascular ROA % Related Terms
LeMaitre Vascular ROA % Historical Data
* Premium members only.
The historical data trend for LeMaitre Vascular's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LeMaitre Vascular ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's ROA % distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
ROA % is displayed in the 30-year financial page.
LeMaitre Vascular (STU:LHU) has a ROA % of 10.76% as of Jun. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on LeMaitre Vascular and its competitors. This is near median its historical median of 9.88. Over the past decade, LeMaitre Vascular's ROA % has ranged from 6.84 to 16.42. According to the industry distribution chart, LeMaitre Vascular ranks #99 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 11.6%.
Is LeMaitre Vascular's ROA % too high?
LeMaitre Vascular's current ROA % of 10.76% is near median its 10-year median of 9.88. Over the past 10 years, this metric has ranged from a low of 6.84 to a high of 16.42. The Medical Devices & Instruments industry median ROA % is 0.53. LeMaitre Vascular's value of 10.76% is 1949.5% above this industry median. Based on the distribution chart, LeMaitre Vascular ranks #99 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, LeMaitre Vascular has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LeMaitre Vascular's ROA % compare to PLSE and XRAY?
According to the Medical Devices & Instruments industry distribution chart, LeMaitre Vascular ranks #99 out of 854 companies for ROA %. This places LeMaitre Vascular in the top 12% of its industry — outperforming the majority of peers. The industry median ROA % is 0.53. LeMaitre Vascular's value of 10.76% is 1949.5% above this benchmark. Historically, LeMaitre Vascular's own ROA % has ranged from 6.84 to 16.42 over the past decade. While the company's 10-year median is 9.88 vs. the industry median of 0.53, LeMaitre Vascular has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.53, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LeMaitre Vascular's current ROA % of 10.76% is 1949.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on LeMaitre Vascular and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LeMaitre Vascular's current ROA % is 10.76%, which is near median its own 10-year median of 9.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeMaitre Vascular stock overvalued right now?
Based on GuruFocus' analysis, LeMaitre Vascular (STU:LHU) is currently considered Modestly Undervalued. The stock's GF Value™ is €81.33, compared to a current price of €70.00 — trading 13.9% below its estimated fair value. The current ROA % is 10.76%, which is near median its 10-year median of 9.88 and 1949.5% above the Medical Devices & Instruments industry median of 0.53. LeMaitre Vascular's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For LeMaitre Vascular (STU:LHU), the current ROA % is 10.76% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LeMaitre Vascular (STU:LHU) Overvalued in 2026?
Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued.
The current stock price of €70.00 is trading 13.9% below its estimated GF Value™ of €81.33.
GuruFocus considers LeMaitre Vascular to be Modestly Undervalued.
Key valuation signals for STU:LHU:
ROA %: 10.76% (near median its 10-year median of 9.88)
GF Value™: €81.33 vs. price of €70.00 (13.9% below fair value)
Industry Position: 1949.5% above the Medical Devices & Instruments median (#99 of 854)
No single metric tells the full story. See the STU:LHU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
98GF Score
Get the complete analysis for STU:LHU
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:LHU has been successfully added to your 
